Drugs / Cyclosporins
Cyclosporins
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT05692739 Comparator | Oct 2022 → Nov 2025 | dry eye syndrome | Barbara Burgos Blasco | Completed | No outcome recorded |
| Phase 4 | NCT01492894 Comparator | Jan 2008 → Oct 2011 | impaired renal function disease | University of Minnesota | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cyclosporins | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05692739 ↗ |
| Known as | Gengraf (cyclosporin) | “Gengraf (cyclosporin)” NCT01492894 ↗ |
| Known as | Neoral (cyclosporin) | “Neoral (cyclosporin)” NCT01492894 ↗ |